Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. SOFIE Co. dba SOFIE
FDA Inspection
•SOFIE Co. dba SOFIE•January 20, 2023

SOFIE Co. dba SOFIE – FDA Inspection, Jan 20, 2023

Record Details

This FDA Inspection record concerns SOFIE Co. dba SOFIE, with an inspection on January 20, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
SOFIE Co. dba SOFIE
Inspection Date
January 20, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Guerlain Ulysse (FDA Associated Person)
  • JoshRenzo N. Ramilo
  • Monika Borkowska Petrik (Issuing Officer)
View Company Profile

ID · 45f7f703-eb06-4086-8792-6fb1746b27f5

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1195181
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

16
  1. 21 CFR 212.60(e)Equipment
  2. 21 CFR 212.20(d)Determination need for investigation
  3. 21 CFR 212.20(e)Written QA procedures established, followed
  4. 21 CFR 212.30(b)Equipment procedures
  5. 21 CFR 212.71(c)Correction of problems
  6. 21 CFR 212.100(a)Written complaint procedures
  7. 21 CFR 212.70(b)Before implementing new procedure establish and document accuracy etc.
  8. 21 CFR 212.50Adequate controls (general)
  9. 21 CFR 212.100(a)Written complaint procedures
  10. 21 CFR 212.20(d)Determination need for investigation

Showing 10 of 16 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of SOFIE Co. dba SOFIE

4
DateClassificationOfficeProject area
February 28, 2018Not classifiedNew Jersey District Office
June 24, 2015NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 28, 2012VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 14, 2010VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for SOFIE Co. dba SOFIE
  • FDA Inspection 1048176 - 2018-02-28
  • FDA Inspection 931454 - 2015-06-24
  • FDA Inspection 769657 - 2012-02-28
  • FDA Inspection 680504 - 2010-09-14

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SOFIE Co. dba SOFIE
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.